Completed PHASE1 INTERVENTIONAL 2-arm NCT00626743

Phase I Study to Investigate the Effect on the Blood Pressure After Oral Administration of SK3530 and Amlodipine

Clinical Trial to Investigate the Influence of SK3530 on the Blood Pressure of Patients With Hypertension Taking Amlodipine

Sponsor: SK Chemicals Co., Ltd.

Conditions Hypertension

Interventions SK3530 100mg, Placebo, Amlodipine

Updated 9 times since 2017 Last updated: Mar 13, 2014 Started: May 31, 2008 Primary completion: May 31, 2009 Completion: Jul 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Hypertension, this trial is completed. The trial is conducted by SK Chemicals Co., Ltd. and has accumulated 9 data snapshots since 2008. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE1
Sep 2024 — Sep 2025 [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2023 — Jul 2024 [monthly]

Completed PHASE1
Dec 2022 — Jan 2023 [monthly]

Completed PHASE1

▶ Show 4 earlier versions

Jan 2021 — Dec 2022 [monthly]

Completed PHASE1
Feb 2019 — Jan 2021 [monthly]

Completed PHASE1
Jun 2018 — Feb 2019 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

May 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

SK Chemicals Co., Ltd.

Data source: SK Chemicals Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pusan, South Korea
• Seoul, South Korea